Krebs von den Lungen-6 (KL-6) is a mucin-like glycoprotein secreted by type II alveolar pneumocytes and bronchial epithelial cells in response to damage and regeneration in the context of ILD. This evidence concerns the gene MUC1 and interstitial lung disease.